Cargando…
Short-term tamoxifen administration improves hepatic steatosis and glucose intolerance through JNK/MAPK in mice
Nonalcoholic fatty liver disease (NAFLD) which is a leading cause of chronic liver diseases lacks effective treatment. Tamoxifen has been proven to be the first-line chemotherapy for several solid tumors in clinics, however, its therapeutic role in NAFLD has never been elucidated before. In vitro ex...
Autores principales: | Fang, Zhiqiang, Xu, Hao, Duan, Juanli, Ruan, Bai, Liu, Jingjing, Song, Ping, Ding, Jian, Xu, Chen, Li, Zhiwen, Dou, Kefeng, Wang, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981902/ https://www.ncbi.nlm.nih.gov/pubmed/36864030 http://dx.doi.org/10.1038/s41392-022-01299-y |
Ejemplares similares
-
Urantide decreases hepatic steatosis in rats with experimental atherosclerosis via the MAPK/Erk/JNK pathway
por: Cui, Haipeng, et al.
Publicado: (2021) -
Hepatic Rather Than Cardiac Steatosis Relates to Glucose Intolerance in Women with Prior Gestational Diabetes
por: Winhofer, Yvonne, et al.
Publicado: (2014) -
Hepatic Glucose Intolerance Precedes Hepatic Steatosis in the Male Aromatase Knockout (ArKO) Mouse
por: Van Sinderen, Michelle L., et al.
Publicado: (2014) -
The Effect and Mechanism of Tamoxifen-Induced Hepatocyte Steatosis in Vitro
por: Zhao, Fei, et al.
Publicado: (2014) -
Absence of Perilipin 2 Prevents Hepatic Steatosis, Glucose Intolerance and Ceramide Accumulation in Alcohol-Fed Mice
por: Carr, Rotonya M., et al.
Publicado: (2014)